• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
F. Hoffmann-La Roche Ltd.Market Share Analysis - Product Image

F. Hoffmann-La Roche Ltd.Market Share Analysis

  • ID: 1405482
  • September 2010
  • 162 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • Apex Biotechnology Corp
  • Bayer HealthCare AG
  • DiaSorin S.p.A
  • LifeScan, Inc.
  • OLYMPUS CORPORATION
  • MORE

F. Hoffmann-La Roche Ltd.Market Share Analysis

Summary

Our new report, “F. Hoffmann-La Roche Ltd. Market Share Analysis” provides in-depth information on F. Hoffmann’s market position in the different medical equipment markets it operates in. The report provides F. Hoffmann’s market share information in eight key market categories - Genetic Testing, Glucose Monitoring, Infectious Immunology, Clinical Chemistry, Immuno Chemistry, Haematology, Insulin Delivery and Histology And Cytology. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets F. Hoffmann operates in - Diabetes Care Devices READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • Apex Biotechnology Corp
  • Bayer HealthCare AG
  • DiaSorin S.p.A
  • LifeScan, Inc.
  • OLYMPUS CORPORATION
  • MORE

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets/Categories Covered
3.1 Diabetes Care Devices
3.1.1 Glucose Monitoring
3.1.2 Insulin Delivery
3.2 In Vitro Diagnostics
3.2.1 Clinical Chemistry
3.2.2 Genetic Testing
3.2.3 Haematology
3.2.4 Histology And Cytology
3.2.5 Immuno Chemistry
3.2.6 Infectious Immunology
3.2.7 Microbiology Culture
4 Company Snapshot
4.1 Key Information
4.2 Company Overview
4.3 Financial Performance
4.4 SWOT Snapshot
5 Business Description
5.1 Business Overview
5.2 Diagnostics
5.2.1 Overview
5.2.2 Financials
5.2.3 Capital Expenditure
5.2.4 Market View
5.2.5 Key Strategies
5.3 Pharmaceuticals
5.3.1 Overview
5.3.2 Financials
5.3.3 Capital Expenditure
5.3.4 Market View
5.4 Major Products and Services
5.4.1 Overview
6 History
7 Business Strategy
7.1 Mission Statement
8 SWOT Analysis
8.1 Overview
8.2 F. Hoffmann-La Roche Ltd. Strengths
8.2.1 Focused Research and Development Activities
8.2.2 Diversified Geographical Presence
8.2.3 Roche Pharmaceuticals Division
8.2.4 Consistent Financial Performance
8.3 F. Hoffmann-La Roche Ltd. Weaknesses
8.3.1 Product Recalls
8.3.2 Pending Lawsuits
8.3.3 Limited Liquidity Position
8.4 F. Hoffmann-La Roche Ltd. Opportunities
8.4.1 Acquisitions
8.4.2 Strong Demand for Oncology Drugs
8.4.3 Product Launches and Approvals
8.4.4 Expansion
8.4.5 Market Growth in Emerging Economies
8.5 F. Hoffmann-La Roche Ltd. Threats
8.5.1 Regulatory Changes
8.5.2 Targeted Cancer Drugs
8.5.3 Counterfeit Drugs
8.5.4 Competitive Conditions
8.5.5 Cost Containment Pressures
9 Competitors
10 Competitive Landscape
10.1 Diabetes Care Devices, Global, Company Share (%), 2009
10.2 In Vitro Diagnostics, Global, Company Share (%), 2009
11 F. Hoffmann-La Roche Ltd. Medical Equipment Market Share Analysis
11.1 F. Hoffmann-La Roche Ltd., Global, Market Share (2009)
11.2 F. Hoffmann-La Roche Ltd., Asia-Pacific, Market Share (2009)
11.2.1 F. Hoffmann-La Roche Ltd., Australia, Market Share (2009)
11.2.2 F. Hoffmann-La Roche Ltd., China, Market Share (2009)
11.2.3 F. Hoffmann-La Roche Ltd., India, Market Share (2009)
11.2.4 F. Hoffmann-La Roche Ltd., Japan, Market Share (2009)
11.2.5 F. Hoffmann-La Roche Ltd., Other Asia-Pacific, Market Share (2009)
11.3 F. Hoffmann-La Roche Ltd., Europe, Market Share (2009)
11.3.1 F. Hoffmann-La Roche Ltd., France, Market Share (2009)
11.3.2 F. Hoffmann-La Roche Ltd., Germany, Market Share (2009)
11.3.3 F. Hoffmann-La Roche Ltd., Italy, Market Share (2009)
11.3.4 F. Hoffmann-La Roche Ltd., Spain, Market Share (2009)
11.3.5 F. Hoffmann-La Roche Ltd., United Kingdom, Market Share (2009)
11.3.6 F. Hoffmann-La Roche Ltd., Other Europe, Market Share (2009)
11.4 F. Hoffmann-La Roche Ltd., Middle East and Africa, Market Share (2009)
11.5 F. Hoffmann-La Roche Ltd., North America, Market Share (2009)
11.5.1 F. Hoffmann-La Roche Ltd., Canada, Market Share (2009)
11.5.2 F. Hoffmann-La Roche Ltd., United States, Market Share (2009)
11.6 F. Hoffmann-La Roche Ltd., South and Central America, Market Share (2009)
11.6.1 F. Hoffmann-La Roche Ltd., Brazil, Market Share (2009)
11.6.2 F. Hoffmann-La Roche Ltd., Other South and Central America, Market Share (2009)
12 F. Hoffmann-La Roche Ltd. Medical Equipment Market Share Analysis by Category
12.1 F. Hoffmann-La Roche Ltd., Global, Category Revenue Share (2009)
12.2 F. Hoffmann-La Roche Ltd., Asia-Pacific, Category Revenue Share (2009)
12.2.1 F. Hoffmann-La Roche Ltd., Australia, Category Revenue Share (2009)
12.2.2 F. Hoffmann-La Roche Ltd., China, Category Revenue Share (2009)
12.2.3 F. Hoffmann-La Roche Ltd., India, Category Revenue Share (2009)
12.2.4 F. Hoffmann-La Roche Ltd., Japan, Category Revenue Share (2009)
12.2.5 F. Hoffmann-La Roche Ltd., Other Asia-Pacific, Category Revenue Share (2009)
12.3 F. Hoffmann-La Roche Ltd., Europe, Category Revenue Share (2009)
12.3.1 F. Hoffmann-La Roche Ltd., France, Category Revenue Share (2009)
12.3.2 F. Hoffmann-La Roche Ltd., Germany, Category Revenue Share (2009)
12.3.3 F. Hoffmann-La Roche Ltd., Italy, Category Revenue Share (2009)
12.3.4 F. Hoffmann-La Roche Ltd., Spain, Category Revenue Share (2009)
12.3.5 F. Hoffmann-La Roche Ltd., United Kingdom, Category Revenue Share (2009)
12.3.6 F. Hoffmann-La Roche Ltd., Other Europe, Category Revenue Share (2009)
12.4 F. Hoffmann-La Roche Ltd., Middle East and Africa, Category Revenue Share (2009)
12.5 F. Hoffmann-La Roche Ltd., North America, Category Revenue Share (2009)
12.5.1 F. Hoffmann-La Roche Ltd., Canada, Category Revenue Share (2009)
12.5.2 F. Hoffmann-La Roche Ltd., United States, Category Revenue Share (2009)
12.6 F. Hoffmann-La Roche Ltd., South and Central America, Category Revenue Share (2009)
12.6.1 F. Hoffmann-La Roche Ltd., Brazil, Category Revenue Share (2009)
12.6.2 F. Hoffmann-La Roche Ltd., Other South and Central America, Category Revenue Share (2009)
13 Key Employees
14 Key Employee Biographies
15 Company Statement
16 Locations And Subsidiaries
16.1 Head Office
16.2 Other Locations & Subsidiaries
17 Financial Deals Landscape
17.1 F. Hoffmann-La Roche Ltd., Deals Volume Summary, 2005 to YTD 2010
18 F. Hoffmann-La Roche Ltd., Deals Summary By Region, 2005 to YTD 2010
19 F. Hoffmann-La Roche Ltd. Detailed Deal Summary
19.1 Venture Financing
19.1.1 BioImagene Receives Financing From Siemens Venture Capital
19.1.2 BioImagene Secures $26 Million In Series D Financing
19.1.3 HistoRx Secures $6 Million In Series B Financing
19.1.4 Cylex Secures $20.5 Million In Series C Financing
19.1.5 NimbleGen Systems Secures $12.5 Million In Mezzanine Round Of Financing
19.1.6 NimbleGen Systems Secures $8.2 Million In Venture Funding
19.1.7 NimbleGen Systems Secures $12.75 Million In Series F Funding
19.1.8 BioImagene Secures $4.2 Million In Series C Financing
19.1.9 BioImagene Secures $4.2 Million In Series B Financing
19.1.10 Cylex Secures $6.4 Million In Series B Financing
19.1.11 HistoRx Secures $1.5 Milliion In Series A Financing
19.2 Partnerships
19.2.1 Roche Molecular Systems Enters Into Research Agreement With Merck Sharp & Dohme
19.2.2 OraSure Technologies Enters Into An Agreement With Roche Diagnostics
19.2.3 Response Biomedical Signs An Agreement With Roche Diagnostics
19.2.4 Roche Signs Distribution Agreement With DxS
19.2.5 Mankind Pharma Enters Into An Agreement With Roche Diagnostics
19.2.6 Roche Diagnostics Signs An Agreement With ARK Diagnostics
19.2.7 Ventana Medical Enters Into An Agreement With Genentech
19.2.8 Roche Diagnostics Enters Into Agreement With OraSure Technologies
19.2.9 Perlegen Sciences Enters Into An Agreement With Genentech
19.2.10 Epigenomics Extends Its Agreement With Roche Diagnostics
19.2.11 Roche Signs An Agreement With 454 Life Sciences
19.2.12 Ventana Medical Systems Enters Into An Agreement With TriPath Imaging
19.2.13 Roche Diagnostics Enters Into An Agreement With Sysmex Deutschland
19.2.14 Roche Diagnostics Signs An Agreement With Diagnostic Products
19.2.15 Roche Enters Into Licensing Agreement With QIAGEN
19.2.16 Olympus America Signs Licensing Agreement With BioImagene
19.2.17 Biosearch Technologies Expands Licensing Agreement With Roche Molecular Systems
19.3 Divestiture - Assets
19.3.1 Scil Technology Acquires Worldwide Rights For CD-RAP From Roche Diagnostics
19.4 Acquisition
19.4.1 Ventana Medical Systems To Acquire BioImagene
19.4.2 Roche Holding To Acquire Medingo From Elron Electronic Industries
19.4.3 Roche Diagnostics Acquires Swisslab
19.4.4 Roche Acquires Ventana Medical Systems
19.4.5 Ventana Medical Acquires Spring Bioscience
19.4.6 Roche Acquires BioVeris
19.4.7 Roche Acquires 454 Life Sciences From CuraGen
19.4.8 Roche Acquires Igen International
20 Recent Developments
20.1 Strategy And Business Planning
20.1.1 Jul 01, 2010: Roche And IBM Collaborate To Develop Nanopore-Based DNA Sequencing Technology
20.1.2 Nov 12, 2009: Ionian Technologies Enters Into Manufacturing Agreement With Roche
20.1.3 Nov 04, 2009: Alnylam Advances RNAi Therapeutic Collaboration With Roche
20.1.4 Nov 04, 2009: Alnylam, Roche Advance RNAi Therapeutic Collaboration Stage
20.1.5 Sep 16, 2009: QIAGEN Acquires Additional Licenses From Roche, Idaho Technology
20.1.6 Sep 10, 2009: GenScript Signs Biology Research Collaboration With Roche
20.1.7 Sep 02, 2009: PTC Enters Into Research, Licensing Agreement With Roche
20.1.8 Jun 09, 2009: Raptor Pharmaceuticals Collaborates With Roche On Therapeutic Delivery Across Blood-Brain Barrier
20.1.9 Jun 09, 2009: Roche Selects Fifth Biologic Target Under Collaboration Agreement With Halozyme
20.1.10 Apr 28, 2009: Roche Diagnostics India Plans To Launch Tissue-Diagnostic Products
20.1.11 Jul 21, 2008: Roche Makes Offer To Acquire All Outstanding Shares Of Genentech For $43.7 Billion
20.2 Financial Announcements
20.2.1 Jul 22, 2010: Roche Reports Net Income Of CHF5.6 Billion For H1 2010
20.2.2 Apr 15, 2010: Roche Reports Sales Of CHF12.2 Billion In Q1 2010
20.2.3 Feb 03, 2010: Roche Reports Net Income Of CHF8.5 Billion In 2009
20.2.4 Oct 15, 2009: Roche Reports Sales Of CHF36.39 Billion In Nine Months Of 2009
20.2.5 Jul 23, 2009: Roche Posts Financial Results For Six Months Ended, 2009
20.2.6 Jul 23, 2009: Roche Declares Net Income Of CHF4.1 Billion In H1 2009
20.2.7 Apr 16, 2009: Roche Reports Total Sales Of CHF11.6 Billion For Q1 2009
20.2.8 Feb 04, 2009: Roche Reports 2008 Results
20.2.9 Oct 21, 2008: Roche Declares Nine Months 2008 Results
20.2.10 Jul 21, 2008: Roche Reports 1H 2008 Results
20.2.11 Apr 18, 2008: Roche Declares Q1 2008 Results
20.2.12 Jan 30, 2008: Roche Reports 2007 Results
20.2.13 Oct 16, 2007: Roche Declares First Nine Months 2007 Results
20.2.14 Jul 19, 2007: Roche Reports H1 2007 Results
20.2.15 Apr 18, 2007: Roche Reports Q1 2007 Results
20.2.16 Feb 07, 2007: Roche Reports Full-Year 2006 Results
20.2.17 Oct 17, 2006: Roche Reports Nine-Months Ended 2006 Results
20.3 Research And Development
20.3.1 Sep 07, 2010: Roche Partners With reMYND To Develop Treatments For Parkinson's And Alzheimer's Disease
20.3.2 Jul 08, 2010: Roche Presents ATHENA Clinical Trial Results
20.3.3 Jun 09, 2009: Roche To Initiate Phase-III Trials For Aleglitazar
20.3.4 May 28, 2009: Bayer HealthCare To Initiate Phase III Trial For Liver Cancer Drug
20.3.5 May 25, 2009: Roche’ Phase III Actemra Study Achieves Goal
20.3.6 Jan 23, 2009: Roche Lays Foundation Stone For R&D Building At Roche Basel
20.3.7 Oct 01, 2008: Roche Invests CHF215 Million In Diagnostics Facility At Penzberg, Munich
20.3.8 Sep 23, 2008: Affitech Accomplishes Second Objective In Roche Antibody Discovery Collaboration
20.4 Corporate Communications
20.4.1 Jul 26, 2010: Roche Appoints Karen Lackey As Vice President And Head Of Medicinal Chemistry
20.4.2 Sep 08, 2009: Roche Announces New Corporate Executive Committee
20.4.3 Dec 08, 2008: Roche Group Research Head To Retire
20.4.4 Oct 02, 2007: Roche Names New CEO For Diagnostics Division
20.4.5 Jul 19, 2007: Roche Appoints CEO
20.5 Legal and Regulatory
20.5.1 Oct 23, 2007: Roche Considers Legal Options In Patent Litigation Case
20.6 Government and Public Interest
20.6.1 Apr 28, 2010: Roche Announces Joint Initiative To Train Healthcare Workers In Africa's Fight Against Cancer
20.6.2 Nov 20, 2009: Roche's Avastin Receives CHMP Negative Opinion
20.6.3 Oct 17, 2009: Genentech, Biogen Receive Complete Response From FDA For Rituxan
20.6.4 Sep 15, 2009: Appeals Court Affirms Patent Infringement Rulings Against Roche
20.6.5 Aug 31, 2009: Roche Wins Approval For Valcyte To Prevent Cytomegalovirus
20.7 Product News
20.7.1 Aug 13, 2009: xCELLigence RTCA System Of Roche Allows For Label-free, Continuous Monitoring Of Cell Phenotypic Changes
20.7.2 Jun 09, 2009: Roche´s NimbleGen Sequence Capture Arrays And xCELLigence Cell Analysis System Stands Among Ten Top Innovative Products Of 2008 In China
20.7.3 Dec 02, 2008: High Throughput Online-Measurement Of Cell Activities Without Labeling: The New xCELLigence RTCA MP Instrument
20.8 Other Significant Developments
20.8.1 Feb 02, 2010: Roche Partners With Direct Relief USA To Donate $5 Million Worth Of ACCU-CHEK To Uninsured Diabetics
20.8.2 May 30, 2007: NorDiag Enters Distribution Agreement With Roche
21 Appendix
21.1 Research Methodology
21.2 Secondary Research
21.3 Primary Research
21.4 Models
21.5 Forecasts
21.6 Expert Panels
21.7 Consulting
21.8 Currency Conversion
21.9 Contact Us
21.10 Disclaimer

Abbott Laboratories
Alere Inc
Animas Corporation
Apex Biotechnology Corp
ARKRAY, Inc.
B. Braun Melsungen AG
Bayer HealthCare AG
Beckman Coulter, Inc.
Becton, Dickinson and Company
Biomerieux Sa
Bio-Rad Laboratories, Inc.
DiaSorin S.p.A
Eli Lilly and Company
Gen-Probe Incorporated
LifeScan, Inc.
Medtronic, Inc.
Novo Nordisk A/S
OLYMPUS CORPORATION
Ortho-Clinical Diagnostics Inc.
Qiagen N.V.
Sanofi-Aventis
Siemens Healthcare
Smiths Medical
Sysmex Corporation
Terumo Corporation

Note: Product cover images may vary from those shown

RELATED PRODUCTS